The Centers for Medicare & Medicaid Services today awarded $347 million in contracts to 16 organizations, including the AHA’s Health Research & Educational Trust, to continue efforts to reduce hospital-acquired conditions and readmissions in the Medicare program. The Hospital Improvement Innovation Networks will work to reduce overall hospital-acquired conditions by 20% and 30-day hospital readmissions by 12%, building on the success of the Partnership for Patients Hospital Engagement Networks and Quality Improvement Organizations. AHA/HRET led the largest HEN projects. “America’s hospitals embrace the ambitious new goals CMS has proposed,” said AHA President and CEO Rick Pollack. “The vast majority of the nation’s 5,000 hospitals were involved in the successful pursuit of the initial Partnership for Patients aims. Our goal is to get to zero incidents. AHA and our members intend to keep an unrelenting focus on providing better, safer care to our patients – working in close partnership with the federal government and with each other.”

Related News Articles

Headline
The Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response yesterday released resources focused on…
Headline
The Federal Emergency Management Agency this month issued COVID-19 pandemic operational guidance for the forthcoming hurricane season. Included in the document…
Headline
The Committee on Ways and Means today convened a hearing examining the disproportionate effect COVID-19 is having on minority communities. “Many communities…
Perspective
In Michigan, African Americans make up 14% of the population … but account for 40% of the COVID-19 deaths. In Chicago: 30% of the population … and 46% of the…
Headline
The Department of Health and Human Services’ Office of Minority Health May 1 announced it will provide funding to help deliver important COVID-19-related…
Headline
Hospitals and health systems continue to provide care for our most vulnerable communities by addressing social needs, educating on COVID-19 risks and…